Thyrocare Technologies Limited

NSEI:THYROCARE 주식 보고서

시가총액: ₹52.0b

Thyrocare Technologies 관리

관리 기준 확인 2/4

Thyrocare Technologies CEO는 Rahul Guha, May2022 에 임명되었습니다 의 임기는 2.5 년입니다. 총 연간 보상은 ₹ 35.00M, 40% 로 구성됩니다. 40% 급여 및 60% 보너스(회사 주식 및 옵션 포함). 는 ₹ 52.72M 가치에 해당하는 회사 주식의 0.1% 직접 소유합니다. 52.72M. 경영진과 이사회의 평균 재임 기간은 각각 1.9 년과 2.8 년입니다.

주요 정보

Rahul Guha

최고 경영자

₹35.0m

총 보상

CEO 급여 비율40.0%
CEO 임기2.5yrs
CEO 소유권0.1%
경영진 평균 재임 기간1.9yrs
이사회 평균 재임 기간2.8yrs

최근 관리 업데이트

Recent updates

Statutory Profit Doesn't Reflect How Good Thyrocare Technologies' (NSE:THYROCARE) Earnings Are

Oct 31
Statutory Profit Doesn't Reflect How Good Thyrocare Technologies' (NSE:THYROCARE) Earnings Are

Thyrocare Technologies Limited (NSE:THYROCARE) Looks Just Right With A 26% Price Jump

Aug 01
Thyrocare Technologies Limited (NSE:THYROCARE) Looks Just Right With A 26% Price Jump

Thyrocare Technologies Limited (NSE:THYROCARE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Jul 26
Thyrocare Technologies Limited (NSE:THYROCARE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)

Jun 12
A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)

Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult

Feb 29
Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult

Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Feb 04
Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly

Dec 08
Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly

Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 08
Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems

Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively

Mar 23
Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively

Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Mar 02
Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First

Feb 01
Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First

Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%

Jan 12
Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%

The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares

Dec 24
The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares

Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive

Dec 17
Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive

Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Nov 30
Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Nov 02
Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates

Nov 01
Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates

CEO 보상 분석

Rahul Guha 의 보수는 Thyrocare Technologies 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

₹840m

Jun 30 2024n/an/a

₹776m

Mar 31 2024₹35m₹14m

₹708m

Dec 31 2023n/an/a

₹655m

Sep 30 2023n/an/a

₹648m

Jun 30 2023n/an/a

₹599m

Mar 31 2023₹32mn/a

₹645m

보상 대 시장: Rahul 의 총 보상 ($USD 414.68K )은 Indian 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 359.99K ).

보상과 수익: Rahul 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Rahul Guha (46 yo)

2.5yrs

테뉴어

₹35,000,004

보상

Mr. Rahul Franklin Guha serves as President of Operations at API Holdings Limited since 2024. He is Managing Director, Chief Executive Officer and Director of Thyrocare Technologies Limited from May 04, 20...


리더십 팀

이름위치테뉴어보상소유권
Rahul Guha
MD, CEO & Chairman2.5yrs₹35.00m0.10%
₹ 52.7m
Alok Jagnani
Chief Financial Officer1.3yrs₹5.55m데이터 없음
K. KallathiKumar
Chief Operating Officerno data₹9.32m0.0030%
₹ 1.6m
Ramjee Dorai
Company Secretary & Compliance Officer10.2yrs₹3.64m0.040%
₹ 20.8m
Pratik Hire
Head of Strategy & Investor Relationsno data데이터 없음데이터 없음
Nitin Chugh
Chief Commercial Officerless than a year데이터 없음데이터 없음
Aditya Shinde
Vice Presidentno data₹5.33m0.0020%
₹ 1.0m
Kapil Gupta
Strategy Managerno data데이터 없음데이터 없음

1.9yrs

평균 재임 기간

46yo

평균 연령

경험이 풍부한 관리: THYROCARE 의 관리팀은 경험 (평균 재직 기간 1.9 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Rahul Guha
MD, CEO & Chairman2.5yrs₹35.00m0.10%
₹ 52.7m
Indumati Gopinathan
Non-Executive Independent Director7.3yrs₹240.00k데이터 없음
Dharmil Sheth
Non-Executive & Non-Independent Director3.2yrs데이터 없음데이터 없음
Hardik Dedhia
Non Executive Director3.2yrs데이터 없음데이터 없음
Dhaval Shah
Non Executive Director3.1yrs데이터 없음데이터 없음
Prapti Gilada
Independent Director1.3yrs₹220.00k데이터 없음
Harshil Vora
Non-Executive Independent Director1.3yrs₹40.00k데이터 없음
Anandh Sundar
Independent Directorno data데이터 없음데이터 없음
Nishant Shah
Independent Directorless than a year데이터 없음데이터 없음

2.8yrs

평균 재임 기간

36yo

평균 연령

경험이 풍부한 이사회: THYROCARE 의 이사회경험(평균 재직 기간 2.8 년)으로 간주되지 않으므로 새 이사회가 필요합니다.